Literature DB >> 25316098

Hepatoblastoma--a rare liver tumor with review of literature.

L Purnima Devi1, Ritesh Kumar, Akash Handique, Mahendra Kumar.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25316098     DOI: 10.1007/s12029-014-9659-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  20 in total

Review 1.  Hepatoblastoma in children: a review.

Authors:  B Raney
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

2.  Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.

Authors:  F Sasaki; T Matsunaga; M Iwafuchi; Y Hayashi; H Ohkawa; M Ohira; T Okamatsu; T Sugito; Y Tsuchida; A Toyosaka; N Nagahara; H Nishihira; Y Hata; J Uchino; K Misugi; N Ohnuma
Journal:  J Pediatr Surg       Date:  2002-06       Impact factor: 2.545

Review 3.  Liver tumours.

Authors:  G Perilongo; E A Shafford
Journal:  Eur J Cancer       Date:  1999-06       Impact factor: 9.162

4.  Extreme thrombocytosis as a diagnostic clue to hepatoblastoma.

Authors:  E A Shafford; J Pritchard
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

5.  Feasibility and toxicity of chemoembolization for children with liver tumors.

Authors:  M H Malogolowkin; P Stanley; D A Steele; J A Ortega
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

6.  Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.

Authors:  J A Ortega; E C Douglass; J H Feusner; M Reynolds; J J Quinn; M J Finegold; J E Haas; D R King; W Liu-Mares; M G Sensel; M D Krailo
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children.

Authors:  Piotr Czauderna; Grzegorz Zbrzezniak; Wojciech Narozanski; Maria Korzon; Maria Wyszomirska; Czeslaw Stoba
Journal:  Pediatr Blood Cancer       Date:  2006-06       Impact factor: 3.167

Review 8.  Where do we stand with hepatoblastoma? A review.

Authors:  J Marco Schnater; S Eleonore Köhler; Wouter H Lamers; Dietrich von Schweinitz; Daniël C Aronson
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

Review 9.  Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience.

Authors:  J B Otte; J Pritchard; D C Aronson; J Brown; P Czauderna; R Maibach; G Perilongo; E Shafford; J Plaschkes
Journal:  Pediatr Blood Cancer       Date:  2004-01       Impact factor: 3.167

10.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

View more
  5 in total

1.  The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma.

Authors:  Ran Yang; Yong Zhan; Yi Li; Shu-Yang Dai; Shi-Wei He; Chun-Jing Ye; Ling-Du Meng; De-Qian Chen; Chen-Bin Dong; Lian Chen; Gong Chen; Kui-Ran Dong; Kai Li; Shan Zheng; Jun Li; Wei Yao; Rui Dong
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

2.  LINC00673 rs11655237 C>T Polymorphism Impacts Hepatoblastoma Susceptibility in Chinese Children.

Authors:  Tianyou Yang; Jiahao Li; Yang Wen; Tianbao Tan; Jiliang Yang; Jing Pan; Chao Hu; Yuxiao Yao; Jiao Zhang; Yijuan Xin; Suhong Li; Huimin Xia; Jing He; Yan Zou
Journal:  Front Genet       Date:  2019-05-24       Impact factor: 4.599

3.  A single-center retrospective study of pediatric hepatoblastoma.

Authors:  Yi Zhang; Weiling Zhang; Suoqin Tang; Liping Chen; You Yi; Pinwei Zhang; Aiping Liu; Tian Zhi; Dongsheng Huang
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

4.  NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children.

Authors:  Tianyou Yang; Yang Wen; Jiahao Li; Tianbao Tan; Jiliang Yang; Jing Pan; Chao Hu; Yuxiao Yao; Jiao Zhang; Yijuan Xin; Suhong Li; Huimin Xia; Jing He; Yan Zou
Journal:  Exp Hematol Oncol       Date:  2019-05-09

5.  Association Between Arg72Pro Polymorphism in TP53 and Malignant Abdominal Solid Tumor Risk in Hunan Children.

Authors:  Zan Liu; Zhenghui Xiao; Ming Li; Yaling Xiao; Xiyang Wang; Jing He; Yong Li
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.